{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:12:15Z","timestamp":1789089135031,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ahj.2025.08.005","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T14:13:33Z","timestamp":1754835213000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Beta-blocker side-effects in clinical practice: A nationwide approach"],"prefix":"10.1016","volume":"291","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-3854","authenticated-orcid":false,"given":"Peter Vibe","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarl Emanuel","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian Kinnberg","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Borup","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Lock","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2025.08.005_bib0001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.recesp.2019.02.023","article-title":"Beta-blockers: historical perspective and mechanisms of action","volume":"72","author":"Oliver","year":"2019","journal-title":"Rev Esp Cardiol Engl Ed"},{"issue":"9146","key":"10.1016\/j.ahj.2025.08.005_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ahj.2025.08.005_bib0003","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of Carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"issue":"7200","key":"10.1016\/j.ahj.2025.08.005_bib0004","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"issue":"36","key":"10.1016\/j.ahj.2025.08.005_bib0005","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2025.08.005_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573402114666180918102735","article-title":"Three generations of \u03b2-blockers: history, class differences and clinical applicability","volume":"15","author":"Do Vale","year":"2019","journal-title":"Curr Hypertens Rev"},{"issue":"8","key":"10.1016\/j.ahj.2025.08.005_bib0007","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/gerona\/gly191","article-title":"Patient-important adverse events of \u03b2-blockers in frail older adults after acute myocardial infarction","volume":"74","author":"Zullo","year":"2019","journal-title":"J Gerontol Ser A"},{"issue":"06","key":"10.1016\/j.ahj.2025.08.005_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2007-979572","article-title":"Adverse CNS-effects of beta-adrenoceptor blockers","volume":"29","author":"Gleiter","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.ahj.2025.08.005_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/HJH.0b013e32834d3d73","article-title":"Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study","volume":"30","author":"Valbusa","year":"2012","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.ahj.2025.08.005_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"\u03b2-Blocker","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahj.2025.08.005_bib0011","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1016\/j.ijcard.2013.05.068","article-title":"Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information","volume":"168","author":"Barron","year":"2013","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.ahj.2025.08.005_bib0012","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2025.08.005_bib0013","first-page":"798","article-title":"Data resource Profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ahj.2025.08.005_bib0014","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.ahj.2025.08.005_bib0015","first-page":"717","article-title":"The Danish unique personal identifier and the Danish Civil Registration System as a tool for research and quality improvement","volume":"31","author":"Mainz","year":"2019","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.ahj.2025.08.005_bib0016","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/CLEP.S471335","article-title":"Cardiovascular Data quality in the Danish National Patient Registry (1977\u20132024): a systematic review","volume":"16","author":"Lund","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.ahj.2025.08.005_bib0017","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/eurheartj\/ehz964","article-title":"Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation","volume":"43","author":"Rasmussen","year":"2022","journal-title":"Eur Heart J"},{"issue":"30","key":"10.1016\/j.ahj.2025.08.005_bib0018","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehab374","article-title":"Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study","volume":"42","author":"Strange","year":"2021","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.ahj.2025.08.005_bib0019","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2025.08.005_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CLEP.S448347","article-title":"Validity of prescription-defined and hospital-diagnosed hypertension compared with self-reported hypertension in Denmark","volume":"16","author":"Bonnesen","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ahj.2025.08.005_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"11","key":"10.1016\/j.ahj.2025.08.005_bib0022","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.ahj.2025.08.005_bib0023","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/bimj.201800298","article-title":"On the estimation of average treatment effects with right-censored time to event outcome and competing risks","volume":"62","author":"Ozenne","year":"2020","journal-title":"Biom J"},{"key":"10.1016\/j.ahj.2025.08.005_bib0024","volume":"2020","author":"Hernan","year":"2020"},{"issue":"10132","key":"10.1016\/j.ahj.2025.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2025.08.005_bib0026","unstructured":"https:\/\/www.r-project.org\/. Accessed August 5, 2025."},{"issue":"1","key":"10.1016\/j.ahj.2025.08.005_bib0027","article-title":"Beta-blockers for hypertension","volume":"2017","author":"Wiysonge","year":"2017","journal-title":"Cochrane Hypertension Group, Editor. Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ahj.2025.08.005_bib0028","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/HJH.0000000000002523","article-title":"Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials","volume":"38","author":"Thomopoulos","year":"2020","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.ahj.2025.08.005_bib0029","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/HJH.0000000000003735","article-title":"Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern","volume":"42","author":"Kreutz","year":"2024","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.ahj.2025.08.005_bib0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1525-1497.2003.20414.x","article-title":"Misperceptions about \u03b2-blockers and diuretics: a national survey of primary care physicians","volume":"18","author":"Ubel","year":"2003","journal-title":"J Gen Intern Med"},{"issue":"5\u20136","key":"10.1016\/j.ahj.2025.08.005_bib0031","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10557-017-6764-8","article-title":"Barriers to beta-blocker use and up-titration among patients with heart failure with reduced ejection fraction","volume":"31","author":"Levitan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2025.08.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132137","article-title":"Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study","volume":"408","author":"Nielsen","year":"2024","journal-title":"Int J Cardiol"},{"issue":"7 Suppl","key":"10.1016\/j.ahj.2025.08.005_bib0033","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:26:51Z","timestamp":1779769611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"alternative-id":["S0002870325002959"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.08.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-blocker side-effects in clinical practice: A nationwide approach","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}